San Antonio Breast Cancer Symposium
06–10 December 2022
San Antonio, TX, USA
Table of Contents
Featured articles
EditorDr Stefan Rauh, Centre Hospitalier Emile Mayrisch, Luxembourg
Miscellaneous
Presented ByDr Burcu Karadal-Ferrena, Albert Einstein College of Medicine, NY, USA
Presented ByDr Irene Kang, City of Hope Orange County, CA, United States
Early-Stage Breast Cancer
Presented ByProf. Claudine Isaacs, Georgetown University Medical Center, DC, USA
Presented ByDr Laura van ‘t Veer, UCLA, CA, USA
HR-positive/HER2-positive Breast Cancer: Trastuzumab-Deruxtecan
Presented ByDr Ian Krop (Yale Cancer Center, CT, USA); Prof. Sara Hurvitz (David Geffen School of Medicine, CA, USA); Prof. Aditya Bardia (Harvard Medical School, MA, USA)
Presented ByProf. Stephen Johnston, The Royal Marsden NHS Foundation Trust, UK
Presented ByDr Yen-Shen Lu, National Taiwan University Hospital, Taiwan
Presented ByDr Erica Mayer (Dana-Farber Cancer Institute, MA, USA); Prof. Virginia Kaklamani (University of Texas Health Sciences Center, TX, USA);
Triple-Negative Breast Cancer
Presented ByProf. François-Clément Bidard, Institut Curie, France
Presented ByDr Li-Peng Ge, Fudan University Shanghai Cancer Center, China
Presented ByDr Maria Contreras-Zarate, University of Colorado, CO, USA
Basic and Translational Research
Presented ByDr Cristina Guarducci, Dana-Farber Cancer Institute, MA, USA
Presented ByProf. Siddhartha Yadav, Mayo Clinic, MN, USA
Presented ByDr Andrea De Censi, Ospedali Galliera, Italy
Presented ByDr Ann Partridge, Dana-Farber Cancer Institute, MA, USA
